ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.
At a time when we are being asked, in every aspect of our work, to do more with less, we can expect streamlined, efficient, pragmatically designed clinical trials to play an increasingly important role in our research enterprise.
Following the ASCO Annual Meeting, the conversations in the news, on social media, and in the hallways of our institutions tend to be dominated by advances in the field—promising new treatments, genetic targets unlocked, gains in overall survival.
Whether you participate in person in Chicago, watch sessions online, or keep up with the meeting outcomes and conversations on social media (or any combination of these), I hope the ASCO Annual Meeting leaves you feeling inspired and, above all, connected.
"It is my hope that 10 years from now we will look back on this time—one in which the pandemic laid bare glaring inequities in health care—as an inflection point," said Michael Burton.
"2020 will be a year we at CancerLinQ look back on with mixed emotion because, in the midst of the pandemic, we achieved a momentous milestone," said Dr. Danielle Potter.
As we celebrate the 20th anniversary of World Cancer Day this February 4, it’s important to recognize that we are making progress in addressing cancer.
As the world’s leading organization of oncology professionals who care for people with cancer, ASCO believes it is critical to understand what the public, including patients, think of, expect, and need from the nation’s cancer care system.
As a physician and future pediatric oncologist, Dr. Rachel Offenbacher believes that providers have the responsibility to be vocal about the critical importance of vaccines.
Predictive analytics, complex treatment pathways, tele-oncology, and more: Dr. Robert M. Daly identifies five trends that are poised to disrupt oncology practice in the coming year.
Clinical trials are the pathway to better treatments, better outcomes, and a future without cancer. We, as investigators, need to believe in them, and be willing to offer them to all patients who are eligible.
A trial of aqueous lidocaine to manage painful intercourse for breast cancer survivors was a small study with a great magnitude of benefit. Do we need to wait for more data, or can we start applying these findings for our patients today?
Blogs
ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.
No Results.
Pages
Advertisement